Abstract
A complex and multifaceted metabolic disease, type 2 diabetes mellitus (T2DM) is
becoming a significant public health concern. Due to their many biological
characteristics, bioactive compounds from herbal medicine have been shown in
multiple studies to have positive benefits on the prevention and control of type
2 diabetes. The scientific community is becoming more interested in curcumin,
one of these therapeutic herbs. The plant Curcuma longa, often known as
turmeric, has a bioactive compound called curcumin in its rhizome. Antioxidant,
cardio-protective, anti-inflammatory, anti-microbial, nephro-protective,
anti-neoplastic, hepato-protective, immunomodulatory, hypoglycemic, and
anti-rheumatic effects are among the various pharmacological and biological
effects of curcumin that have been reported by both in vitro and in vivo
studies. Curcumin extract increases -cell functioning, delays the onset of
diabetes, inhibits -cell death, and lowers insulin resistance in animal models.
Recent preclinical studies and clinical trials have shown strong evidence of
curcumin’s vital roles in preventing type 2 diabetes via a number of pathways.
Thus, the antidiabetic action of curcumin and its many mechanisms are
comprehensively summarized in this study. The findings indicated that curcumin’s
anti-inflammatory, anti-oxidant, antihyperglycemic, antiapoptotic, and
antihyperlipidemic properties, among others, account for its success in treating
type 2 diabetes. These findings suggest that curcumin could be a potential
option for T2DM prevention and management.
Keywords
curcumin - type 2 diabetes mellitus - antidiabetic activity - molecular mechanisms,
antioxidant
